Patent · US Active

Use of isothiocyanate derivatives as anti-myeloma agents

US8772251B2 · kind B2 · utility

56Cited by

0References

4Claims

0Family size

Assignee

INDENA S.P.A. · IT

Inventors

Paolo Morazzoni · Milano, IT
Carla Manzotti · Monza, IT
Gabriele Fontana · Milano, IT
Antonella Riva · Milano, IT
Renato Iori · Milano, IT

Key dates

Filing date	Dec 17, 2008
Grant date	Jul 8, 2014
Priority date	—
Expiry date	Dec 9, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns the use of glucomoringin and of its des-thio-glucoside having the following formulae (I, II): for the preparation of a medicament for the treatment of myeloma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.